NINDS Neuroscience Funding Announcements

Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

Preclinical Development Facility CINAPS Drug Optimization Program Request for Information (RFI)
Release Date: April 20, 2005
Announcement Number: NOT-NS-05-008

Funding Contact: Helene Braun
Program Area: Neurodegeneration, Contracts Management Branch

Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS) is exploring the market interest and capabilities relating to the development of a contract facility with the ability to conduct preclinical animal drug studies in different models of Parkinson's Disease. The contract facility would have 3 functions: 1) conduct efficacy and pharmacokinetic studies in a range of rodent models of Parkinson's disease; 2) conduct some toxicology studies; 3) provide research support for the neuroprotection drug selection process (CINAPS), such as literature reviews and assembling drug dossiers.

Choose an option to view additional funding announcements